Publication date: Jun 28, 2023
Globally, COVID-19 affected radiopharmaceutical laboratories. This study sought to determine the economic, service, and research impacts of COVID-19 on radiopharmacy. This online survey was conducted with the participation of employees from nuclear medicine and radiopharmaceutical companies. The socioeconomic status of the individuals was collected. The study was participated by 145 medical professionals from 25 different countries. From this work, it is evident that 2-deoxy-2-[18F]fluoro-D-glucose (2-[F]FDG), and Tc-labeled macro aggregated albumin Tc-MAA were necessary radiopharmaceuticals used by 57% (83/145and 34% (49/145;) respondents, respectively for determining how COVID infections affect a patient’s body. The normal scheduling procedure for the radiopharmacy laboratory was reduced by more than half (65%; 94/145). In COVID-19, 70% (102/145) of respondents followed the regulations established by the local departments. Throughout the pandemic, there was a 97% (141/145) decrease in all staffing recruitment efforts. The field of nuclear medicine research, as well as the radiopharmaceutical industry, were both adversely affected by COVID-19.
Open Access PDF
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | COVID-19 |
| drug | DRUGBANK | D-glucose |
| disease | MESH | infections |
| drug | DRUGBANK | Coenzyme M |
| drug | DRUGBANK | Dextrose unspecified form |
| disease | MESH | influenza |
| disease | MESH | lifestyle |
| disease | MESH | uncertainty |
| disease | IDO | infection |
| drug | DRUGBANK | Trestolone |
| disease | VO | USA |
| drug | DRUGBANK | Etoperidone |
| disease | VO | protocol |
| disease | IDO | production |
| disease | VO | population |
| disease | IDO | process |
| disease | VO | viable |
| pathway | REACTOME | Glucose metabolism |
| disease | VO | effective |
| disease | MESH | complications |
| disease | VO | frequency |
| disease | MESH | sore throat |
| disease | VO | Imovax ID |
| disease | VO | organization |
| disease | VO | efficient |
| disease | IDO | quality |
| drug | DRUGBANK | Spinosad |
| disease | VO | time |
| disease | MESH | Obstructive sleep apnea |
| disease | MESH | pneumonia |
| disease | MESH | inflammation |
| disease | MESH | cancer |
| disease | MESH | interstitial pneumonia |
| disease | VO | vaccination |
| disease | MESH | pulmonary embolism |
| disease | MESH | contraindications |
| drug | DRUGBANK | Iodine |
| disease | MESH | cardiovascular diseases |
| drug | DRUGBANK | Medical air |